Inhibrx Biosciences Inc share price logo

Inhibrx Biosciences Inc

NASDAQ: INBX

Small Cap

$101.71

+2.10

(+2.11%)

as on

Inhibrx Biosciences Inc Stock Performance

as on September 29, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $98.51
    $104.55
    downward going graph

    3.15%

    Downside

    2.79%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $28.16
    $155.29
    downward going graph

    72.31%

    Downside

    52.68%

    Upside

    downward going graph

Inhibrx Biosciences Inc share price movements today

Previous Close
$99.61
Open
$100.00
Volume
240.7K
Market Cap
$1.5B
Day's Low - High
$98.51 - $104.55
52 Week Low - High
$28.16 - $155.29

Inhibrx Biosciences Inc Historical Returns

1 Month Return
-17.58 %
3 Month Return
+ 6.5 %
1 Year Return
+ 214.79 %
3 Year Return
+ 454.28 %
5 Year Return
+ 199.68 %

Inhibrx Biosciences Inc Stock Fundamentals & Key Indicators

Check Inhibrx Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.5B

EPS (TTM)

-8.88

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-11.22

Industry PE ratio

-8.79

PEG Ratio

-0.6029374592185255

EBITDA

-120.4M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

1893.60%

Inhibrx Biosciences Inc Stock Valuation

Track how Inhibrx Biosciences Inc P/E has moved over time to understand its valuation trends.

Inhibrx Biosciences Inc in the last 5 years

  • Overview

  • Trends

Lowest (-20.30x)

December 31, 2021

Industry (-8.79x)

December 31, 2025

Today (-8.74x)

December 31, 2025

Highest (0.13x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -8.74x

Inhibrx Biosciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Inhibrx Biosciences Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$1.5B199.68%-11.220.00%0.00%
StrongBuy$43.9B628.83%-23.130.00%0.00%
Neutral$79.4B-47.93%-24.92-12.57%0.00%
StrongBuy$133.4B189.75%30.3886.04%0.00%
Buy$81.1B23.99%18.8284.86%0.47%

Stock Returns calculator for Inhibrx Biosciences Inc Stock including INR - Dollar returns

The Inhibrx Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Inhibrx Biosciences Inc investment value today

Current value as on today

₹3,40,615

Returns

₹2,40,615

(+240.62%)

Returns from Inhibrx Biosciences Inc Stock

₹2,14,794 (+214.79%)

Dollar Impact

₹25,821 (+25.82%)

Analyst Recommendation on Inhibrx Biosciences Inc Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Inhibrx Biosciences Inc. Average target price of $266.67

Inhibrx Biosciences Inc Share Price Target

Get share price movements and forecasts by analysts on Inhibrx Biosciences Inc.

What analysts predicted

61.86%UPSIDE

Target Price

$266.67

Current Price

$101.71

Analyzed by

2 Analysts

High

$245

Target

$266.67

Low

$230

Inhibrx Biosciences Inc target price $266.67, a slight upside of 61.86% compared to current price of $101.71. According to 2 analysts rating.

Indian Investors' Interest in Inhibrx Biosciences Inc Stock

Search interest for Inhibrx Biosciences Inc Stock has increased by 103% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:103% versus previous 30 day period

Inhibrx Biosciences Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
0
-
0
-
1
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
-
Operating Income
-73
-160
-46
-49
-42
-27
-33
-30
-30
-32
EBITDA
-70
1,863
-43
-47
-39
-24
-31
-29
-29
-30
Interest Expense
8
5
-
-
2
3
3
3
3
5
Depreciation
0
-
0
0
0
0
0
0
0
0
Income Before Tax
-78
1,858
-43
-47
-43
-28
-35
-32
-33
-36
Income Tax Expense
-
0
-
-
-
0
-
-
-
0
Net Income
-78
1,858
-43
-47
-43
-28
-35
-32
-33
-36
Net Profit Margin
0.00%
100.00%
0.00%
-589.00%
0.00%
49.08%
0.00%
0.00%
0.00%
0.00%

Inhibrx Biosciences Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
8
8
9
12
7
2
1
0
1
Gross Profit
-17
-24
-38
-
4
-107
0
-2
-1
Operating Income
-19
-29
-40
-67
-76
-129
-219
-331
-135
EBITDA
-19
-28
-39
-66
-76
-125
-206
1,703
-125
Interest Expense
2
1
5
10
5
16
31
13
12
Depreciation
0
0
1
1
-
1
1
2
2
Income Before Tax
-21
-30
-50
-75
-81
-145
-239
1,687
-140
Income Tax Expense
0
0
0
0
0
0
0
0
0
Net Income
-19
-31
-51
-76
-81
-145
-241
1,687
-140
Net Profit Margin
-220.88%
-346.05%
-426.86%
-473.82%
62.27%
-4926.73%
33.83%
-1042.50%
-91.00%

Inhibrx Biosciences Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-78
1,828
-43
-47
-43
-28
-35
-32
-33
-36
Operating Cash Flow
-63
-57
-30
-43
-35
-29
-33
-30
-38
-29
Investing Cash Flow
-1
-1
0
0
0
-
0
-
-
0
Financing Cash Flow
38
32
-
-
99
-
0
1
75
1
Change in Cash
-25
-25
-30
-43
63
-29
-33
-28
37
-28

Inhibrx Biosciences Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-22
-31
-51
-76
-81
-145
-239
1,687
-140
Operating Cash Flow
-18
-23
-32
-47
-80
-115
-193
-194
-129
Investing Cash Flow
-1
-1
-1
-1
0
0
-4
-2
0
Financing Cash Flow
13
13
43
166
83
258
201
71
101
Change in Cash
-6
-11
9
117
2
142
4
-125
-28

Mutual Funds that own Inhibrx Biosciences Inc Stock

Check out the Mutual Funds with significant holdings in Inhibrx Biosciences Inc.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
3.211237%
472619
SMALLCAP World Fund Inc
2.400463%
353292
Fidelity Salem Street Trust
0.694899%
102273
Fidelity Concord Street Trust
0.677267%
99678
VANGUARD SCOTTSDALE FUNDS
0.355137%
52268

Global Institutional Holdings in Inhibrx Biosciences Inc

Funds
Holdings
Joseph Edelman
8.82%
Andreas Halvorsen
7.64%
Vanguard
4.06%
VANGUARD INDEX FUNDS
3.21%
iShares
3.17%

Inhibrx Biosciences Inc News & Key Events

  • img

    Today's Timeline - 08 September

    Tue, 05:10 PM

    -

    Inhibrx announces positive Phase 2 results for INBRX-106 in HNSCC, showing significant efficacy compared to pembrolizumab alone.

Insights on Inhibrx Biosciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, INBX stock has moved up by 74.2%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 100.0K → 1.3M (in $), with an average increase of 92.3% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, INBX has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 678.8% return, outperforming this stock by 464.0%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -32.83M → -36.65M (in $), with an average decrease of 5.7% per quarter

About Inhibrx Biosciences Inc

Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company, which includes a pipeline of novel biologic therapeutic candidates, developed using proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize multivalent formats where the precise valency can be optimized in a target-centric way to mediate what is believed to be the most appropriate agonist function. The company was founded by Brendan P. Eckelman on January 8, 2024 and is headquartered in La Jolla, CA.
OrganisationInhibrx Biosciences Inc
Headquarters11025 North Torrey Pines Road, La Jolla, CA, 92037, US
IndustryBiotechnology
CEOMark Lappe
E-voting on sharesClick here to vote

Key Management of Inhibrx Biosciences Inc

Name

Title

Mr. Mark Paul Lappe

Founder, CEO & Chairman

Mr. David J. Matly M.B.A.

President

Ms. Kelly Devine Deck B.S., CPA, M.S.

Executive VP, CFO & Treasurer

Dr. Ashraf Amanullah Ph.D.

Executive VP & Chief Technical Operations Officer

Ms. Bonne Adams M.B.A.

Vice President of Operations

Ms. Kate Burke CPA, M.B.A.

Vice President of Accounting

Dr. Carlos Bais Ph.D.

EVP & Chief Scientific Officer

Ms. Leah Pollema J.D.

VP, General Counsel & Corporate Secretary

Dr. Josep Garcia Ph.D.

Executive VP & Chief Clinical Development Officer

FAQs

What is Inhibrx Biosciences Inc share price today?

Inhibrx Biosciences Inc share price today is $101.71 as on at the close of the market. Inhibrx Biosciences Inc share today touched a day high of $104.55 and a low of $98.51.

What is the 52 week high and 52 week low for Inhibrx Biosciences Inc share?

Inhibrx Biosciences Inc share touched a 52 week high of $155.29 on and a 52 week low of $28.16 on . Inhibrx Biosciences Inc stock price today i.e. is closed at $101.71,which is 34.50% down from its 52 week high and 261.19% up from its 52 week low.

What is Inhibrx Biosciences Inc's market capitalisation today?

Inhibrx Biosciences Inc market capitalisation is $0.00T as on .

How to invest in Inhibrx Biosciences Inc Stock (INBX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Inhibrx Biosciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Inhibrx Biosciences Inc Shares that will get you 0.0147 shares as per Inhibrx Biosciences Inc share price of $101.71 per share as on September 29, 2026 at 8:46 am IST.

What is the minimum amount required to buy Inhibrx Biosciences Inc Stock (INBX) from India?

Indian investors can start investing in Inhibrx Biosciences Inc (INBX) shares with as little as ₹95.980003356934 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.80 in Inhibrx Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Inhibrx Biosciences Inc share’s latest price of $101.71 as on September 29, 2026 at 8:46 am IST, you will get 0.0983 shares of Inhibrx Biosciences Inc. Learn more about fractional shares .

What are the returns that Inhibrx Biosciences Inc has given to Indian investors in the last 5 years?

Inhibrx Biosciences Inc stock has given 199.68% share price returns and 29.13% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?